Equities

Verisante Technology Inc

VER.H:NEX

Verisante Technology Inc

Actions
  • Price (CAD)0.01
  • Today's Change0.00 / 0.00%
  • Shares traded1.10k
  • 1 Year change-33.33%
  • Beta--
Data delayed at least 15 minutes, as of Apr 25 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Verisante Technology, Inc. is a Canada-based company. The Company is engaged in seeking out opportunities to acquire a business, such as a provider of technologies and services, offering scalable solutions. It intends to focus its search on companies that meet its acquisition target characteristics within the life sciences sectors, specifically medical devices; pharmaceuticals; health data information technology infrastructure; and health data analytics and big data.

  • Revenue in CAD (TTM)0.00
  • Net income in CAD-86.92k
  • Incorporated2006
  • Employees8.00
  • Location
    Verisante Technology Inc170-422 Richards Street,VANCOUVER V6B 2Z4CanadaCAN
  • Phone+1 (604) 716-5133
  • Fax+1 (604) 605-0507
  • Websitehttps://www.verisante.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Health Logic Interactive Inc0.00-212.39k235.26k-----------0.0316-0.03160.00-0.15090.00-------186.79661.38---------------0.5265--------81.16------
Imaging Dynamics Company Ltd103.65k-1.02m309.92k23.00------2.99-0.0984-0.09840.01-0.36630.31043.015.47---304.56-150.07----46.4269.30-981.14-424.340.0412-6.28-----53.60-32.66-70.90------
Wellness Center USA Inc534.89k-1.63m316.10k4.00------0.591-0.0092-0.00920.0031-0.02492.231.10-----892.24-2,092.00----67.8137.82-399.36-1,462.730.011-1.95----4,699.20-4.3463.70------
Forza Innovations Inc172.84k-4.28m344.78k--------1.99-0.0066-0.00660.0003-0.00220.2998-------742.67-259.08----76.78---2,477.65-376.53---4.85------80.2414.77------
Electromedical Technologies Inc1.84m-3.62m346.78k6.00------0.188-0.0078-0.00780.0036-0.00621.284.65194.91224,801.70-251.35-340.23----77.5175.94-195.82-406.260.1134-1.51----17.3014.8426.05------
Verisante Technology Inc0.00-86.92k439.22k8.00--35.07-----0.0023-0.00230.000.00030.00-------161.65188.29-291.14--------------0.42710.00-----107.53------
G Medical Innovations Holdings Ltd-136.72bn-136.72bn468.24k----0.0016----------8.78------------------------1.52--0.306--80.47--7.68------
Sientra Inc123.46m-81.12m490.46k304.00------0.004-5.45-5.438.10-2.820.59051.152.82297,036.20-38.80-45.08-163.51-76.2242.1155.37-65.71-103.790.3106-14.232.20--12.2319.90-17.26--14.01--
Motus GI Holdings Inc436.14k-17.59m502.27k15.00--0.0406--1.15-25.61-25.610.39451.740.02571.164.7321,266.67-103.47-80.63-153.17-112.32-78.37-44.53-4,033.54-6,160.581.61-17.610.4582---46.1154.7030.81---28.25--
Data as of Apr 25 2024. Currency figures normalised to Verisante Technology Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.